AzTrials
AzTrials

HealthyCOSI@PFCNCT02517190

Effects of Repeated Short-term Microgravity During Parabolic Flight Conditions on Neuro-endocrine, Immune and Metabolic Changes

A study testing Parabolic flight, neuro-endocrine measurements and immunological measurements in people with Healthy, run by University Hospital, Caen at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

From previous parabolic flight campaigns completed by our research group investigators gathered data showing important changes in neuro-endocrine and also immunological changes. This experiment now will complete the data set-up obtained during the MARS500 study on how these respective individuals will re-act to highly… Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Healthy
What is being tested?
Parabolic flight, neuro-endocrine measurements and immunological measurements
Could I receive a placebo?
No, everyone receives an active treatment
How many people
6 participants
Where
1 siteFrance
Study dates
May 2012to Jan 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Healthy volunteers (men or women)
  • Aged from 18 to 65
  • Affiliated to a Social Security system and, for non-French resident, holding a European Health Insurance Card (EHIC)
  • Who accepted to take part in the study
  • Who have given their written stated consent
  • Who participated in the MARS500 experiment
  • Who has passed a medical examination similar to a standard aviation medical examination for private pilot aptitude. There will be no additional test performed for subject selection.

Who cannot join

  • Person who took part in a previous biomedical research protocol, of which exclusion period is not terminated
  • Pregnant women

Trial locations and contacts

1 site in 1 country.

France1 site
  • Umr Ucbn/Inserm U1075 Comete

    Caen, Basse-Normandie, 14032

Other trials in France

About this study

From previous parabolic flight campaigns completed by our research group investigators gathered data showing important changes in neuro-endocrine and also immunological changes. This experiment now will complete the data set-up obtained during the MARS500 study on how these respective individuals will re-act to highly physically and emotionally challenging situations during a parabolic flight.

This add-on experiment to MARS500 will enable answering to the following questions i) if the stress response systems - when compared for two conditions but in the same individuals - do react uniformly and ii) if those subjects prone to have adequate stress response pattern will show gradually less immune modulation effects.

The understanding of the complex interactions of stress and immunity under chronic and acute stress conditions might help to enable adequate health and immune monitoring and might as well suggest suitable countermeasures for the prevention of the unwanted immunological effects during long-term confinement and space missions.

Conditions
Healthy
Being tested
Parabolic flight, neuro-endocrine measurements, immunological measurements, cellular energy metabolism measurements
Keywords
volunteers

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Parabolic flightOther

  • neuro-endocrine measurementsOther

    psychic stress tests, stress hormones: prolactin, cortisol, endo-cannabinoids

  • immunological measurementsOther

    blood cell counts, B2 integrins, cytokines, C-reactive protein

  • cellular energy metabolism measurementsOther

    purines, lactate

Study groups in NCT02517190
Study groupRoleWhat they receive
Stress response measurementsOtherNot described
Receives: Other: Parabolic flight; Other: neuro-endocrine measurements; Other: immunological measurements; Other: cellular energy metabolism measurements

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. neuro-endocrine measurements composite

    prolactin, cortisol, endo-cannabinoids

    Measured: baseline

  2. immunological measurements composite

    blood cell counts, B2 integrins, cytokines, C-reactive protein

    Measured: baseline

  3. cellular energy metabolism measurements composite

    purines, lactate

    Measured: baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Aug 2015 (estimated)
  2. Study startMay 2012
  3. Primary completionJan 2014
  4. Study completionJan 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
6 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02517190
Sponsor's protocol ID
12-024
Acronym
COSI@PFC
Status last verified
Aug 2015
First submitted
23 Jul 2015
Last updated
6 Aug 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Parabolic flight, neuro-endocrine measurements and immunological measurements in people with Healthy, run by University Hospital, Caen at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Aug 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

neuro-endocrine measurements composite (time frame: baseline). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Aug 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in